Where does Erasmus University Medical Center Rotterdam rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Erasmus University Medical Center Rotterdam ranks #6,141 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Erasmus University Medical Center Rotterdam hold?

Erasmus University Medical Center Rotterdam holds 55 US utility patents granted between 2015 and 2025, spanning 19 technology areas.

What is Erasmus University Medical Center Rotterdam's Innovation Score?

Erasmus University Medical Center Rotterdam has an Innovation Score of 42.3 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Erasmus University Medical Center Rotterdam's patent grant rate increasing or decreasing?

Erasmus University Medical Center Rotterdam's recent grant velocity is +65% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Erasmus University Medical Center Rotterdam's patents?

Erasmus University Medical Center Rotterdam's patents average 13.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Erasmus University Medical Center Rotterdam

Q: What technology areas does Erasmus University Medical Center Rotterdam focus on?

Erasmus University Medical Center Rotterdam's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 31 patents, ranking #485 of 7,863 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

Q: How is the Erasmus University Medical Center Rotterdam patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 55 granted patents across 19 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Erasmus ranks #6,141 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 19 technology areas.

#6,141
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.3/100): 13.2
avg claims per patent: +65%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6141 · Foreign Corporation #6,141 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,141/49,997
PHOTO-FINISH East Carolina…
CPC-FOCUS G01N · 19 areas
INNOV-PAR 42.3/100
CLAIMS-RICH 13.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +65% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: East Carolina University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Erasmus’s 42.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (33%) Velocity 5.1 pts (12%) Breadth 15.4 pts (36%) Claim depth 7.9 pts (19%)

Qualcomm Incorporated · highest

85
Auspex Pharmaceuticals · near

42
Erasmus University… · this assignee

42
Invoy Holdings · near

42
Nagasaki University · near

42
SAP Portals Israel · near

42
3D Lighting… · lowest

7

What this shows Erasmus's Innovation Score is 42.3/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Erasmus?

Each dot is one of Erasmus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Erasmus’s own 13.2 claims/patent is at or below the 13.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Erasmus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Erasmus's grants concentrate

Erasmus University Medical Center Rotterdam is a focused PatentsView assignee: 19 CPC subclasses with 56.4% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2020 (11 grants) versus a trough of 1 in 2015. By volume, Erasmus sits between Eugene Technology Co., Ltd. and Freeport Minerals Corporation.

Erasmus's three-year grant acceleration

From 2019–2021 to 2022–2024, Erasmus University Medical Center Rotterdam moved from 21 to 16 grants (0.76x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Eugene Technology

55
East Carolina Uni…

55
Ellenberger & Poe…

55
Entellus Medical

55
Exo Imaging

55
Floricultura B V

55
FMC Kongsberg Sub…

55
Freeport Minerals

55
Erasmus Universit… ◀

55

What this shows Erasmus holds 55 patents at rank #6,142, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Erasmus

By rank, the assignees closest to #6,142 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Erasmus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Erasmus, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Erasmus ranks #485 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Invoy Holdings Inc. 42 SAP Portals Israel Ltd 42 Nagasaki University 42 Auspex Pharmaceuticals, Inc. 42

Similar claim depth

Nearest assignees by average claims per patent (13.2 here).

Integrated DNA Technologies, Inc. 13.2 avg Lifetime Products, Inc. 13.2 avg Nicoventures Trading Limited 13.2 avg Kuraray Co., Ltd. 13.2 avg

Erasmus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Erasmus University Medical Center Rotterdam patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.8%
2016	3	5.5%
2017	5	9.1%
2018	7	12.7%
2019	4	7.3%
2020	11	20.0%
2021	6	10.9%
2022	6	10.9%
2023	5	9.1%
2024	5	9.1%
2025partial year	2	3.6%

Which technologies does Erasmus University Medical Center Rotterdam patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 31

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 23

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 21

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 20

C07K - Peptides 13

A61B - DIAGNOSIS; SURGERY; Identification 9

C12Y - Enzymes 7

Y02A - Technologies FOR Adaptation TO Climate Change 5

B06B - Methods OR Apparatus FOR Generating OR Transmitting Mechanical Vibrations OF Infrasonic, Sonic, OR Ultrasonic Frequency, ; e.g.; FOR Performing Mechanical Work IN General 2

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 2

C07D - Heterocyclic Compounds 2

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

G02B - Optical Elements, Systems OR Apparatus 1

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 1

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Erasmus University Medical Center Rotterdam's patent record in context - here's where to go next.

Erasmus University Medical Center Rotterdam's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 56.4% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #6,141 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Erasmus University Medical Center Rotterdam against Eugene Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.